Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
about
Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?Pharmacological Inhibition of the Pseudomonas aeruginosa MvfR Quorum-Sensing System Interferes with Biofilm Formation and Potentiates Antibiotic-Mediated Biofilm Disruption.The pharmacological treatment of bronchiectasis.
P2860
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@ast
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@en
type
label
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@ast
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@en
prefLabel
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@ast
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@en
P2093
P2860
P356
P1476
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
@en
P2093
Diego J Maselli
Holly Keyt
Marcos I Restrepo
P2860
P356
10.3390/IJMS18051062
P407
P5008
P577
2017-05-16T00:00:00Z